Renaissance Technologies Portfolio holdings
Renaissance Technologies is a hedge fund firm that trades with computer models built on mathematics and statistics. It began in 1978 as Monemetrics, founded by Jim Simons, a mathematician and former Cold War codebreaker, and took its current name in 1982. The firm launched its Medallion Fund in 1988 and staffs its research with mathematicians, statisticians, physicists, astronomers and computer scientists. Medallion trades over short time spans across many asset types, and it has been closed to outside investors since 1993, open only to current and past employees and their families.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$521M |
| 2 |
Becton Dickinson
BDX
|
+$411M |
| 3 |
GE Aerospace
GE
|
+$361M |
| 4 |
IBM
IBM
|
+$305M |
| 5 |
Philip Morris
PM
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$455M |
| 2 |
NetEase
NTES
|
+$451M |
| 3 |
Medtronic
MDT
|
+$398M |
| 4 |
NVIDIA
NVDA
|
+$348M |
| 5 |
Netflix
NFLX
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Technology | 14.39% |
| 3 | Financials | 10.63% |
| 4 | Industrials | 9.92% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$125B
| $876M | 0.97% |
14,302,900
+3,456,300
| +32% | +$216M |
2016 Q2
6 quarters
|
|
2
Novo Nordisk
NVO
$173B
| $844M | 0.93% |
31,462,400
+2,739,800
| +10% | +$69.7M |
2013 Q2
18 quarters
|
|
|
3
ExxonMobil
XOM
$754B
| $832M | 0.92% |
9,948,354
+6,295,900
| +172% | +$521M |
2017 Q3
1 quarter
|
|
4
Humana
HUM
$50.1B
| $804M | 0.89% |
3,241,700
-418,400
| -11% | -$103M |
2015 Q2
10 quarters
|
|
5
Amgen
AMGN
$249B
| $796M | 0.88% |
4,579,445
+661,745
| +17% | +$117M |
2013 Q2
18 quarters
|
|
6
VeriSign
VRSN
$27.4B
| $781M | 0.86% |
6,826,054
+916,278
| +16% | +$102M |
2013 Q2
18 quarters
|
|
7
PepsiCo
PEP
$182B
| $779M | 0.86% |
6,497,262
+996,562
| +18% | +$114M |
2013 Q2
18 quarters
|
|
8
Colgate-Palmolive
CL
$74.3B
| $649M | 0.72% |
8,601,900
-1,002,200
| -10% | -$73.2M |
2013 Q2
18 quarters
|
|
9
Palo Alto Networks
PANW
$311B
| $635M | 0.7% |
26,274,600
+4,087,200
| +18% | +$99.4M |
2015 Q2
10 quarters
|
|
10
Domino's
DPZ
$10.3B
| $621M | 0.68% |
3,286,400
+64,100
| +2% | +$11.9M |
2013 Q2
18 quarters
|
|
11
Home Depot
HD
$328B
| $617M | 0.68% |
3,255,400
+602,600
| +23% | +$104M |
2016 Q2
6 quarters
|
|
|
12
Philip Morris
PM
$325B
| $608M | 0.67% |
5,753,131
+2,779,331
| +93% | +$296M |
2016 Q3
5 quarters
|
|
13
Crown Castle
CCI
$37.8B
| $599M | 0.66% |
5,395,800
+481,800
| +10% | +$52M |
2015 Q1
11 quarters
|
|
14
Align Technology
ALGN
$10.9B
| $581M | 0.64% |
2,614,100
+576,900
| +28% | +$131M |
2013 Q2
18 quarters
|
|
15
Cboe Global Markets
CBOE
$32.8B
| $563M | 0.62% |
4,520,000
+130,300
| +3% | +$15.3M |
2013 Q2
18 quarters
|
|
16
Gilead Sciences
GILD
$205B
| $542M | 0.6% |
7,564,948
-2,665,951
| -26% | -$202M |
2014 Q4
12 quarters
|
|
17
Intuitive Surgical
ISRG
$159B
| $526M | 0.58% |
4,321,800
+464,400
| +12% | +$58.1M |
2013 Q2
18 quarters
|
|
18
Johnson & Johnson
JNJ
$662B
| $485M | 0.53% |
3,469,800
-836,400
| -19% | -$117M |
2015 Q3
9 quarters
|
|
|
19
IBM
IBM
$244B
| $478M | 0.53% |
3,258,499
+2,099,858
| +181% | +$305M |
2017 Q1
3 quarters
|
|
|
20
Becton Dickinson
BDX
$54B
| $444M | 0.49% |
2,126,366
+1,961,801
| +1,192% | +$411M |
2017 Q3
1 quarter
|
|
|
21
NVIDIA
NVDA
$5.16T
| $437M | 0.48% |
90,251,720
-70,152,280
| -44% | -$348M |
2013 Q4
16 quarters
|
|
|
22
NetEase
NTES
$71.8B
| $427M | 0.47% |
6,190,500
-7,224,750
| -54% | -$451M |
2013 Q2
18 quarters
|
|
23
Vertex Pharmaceuticals
VRTX
$137B
| $427M | 0.47% |
2,847,917
+1,479,897
| +108% | +$219M |
2017 Q1
3 quarters
|
|
|
24
GE Aerospace
GE
$325B
| $427M | 0.47% |
5,102,824
+3,777,561
| +285% | +$361M |
2017 Q1
3 quarters
|
|
25
Walmart Inc
WMT
$962B
| $412M | 0.45% |
12,516,939
-5,612,061
| -31% | -$172M |
2016 Q1
7 quarters
|
|
Similar funds
Renaissance Technologies's Q4 2017 Portfolio in Review
As of Q4 2017, Renaissance Technologies held 3,692 positions worth $90.7B, up 6.7% from $85B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Renaissance Technologies's Q4 2017 filing shows 521 new, 1,724 increased, 1,031 reduced and 386 closed positions. Its largest new stake was Alphabet (Google) Class C: 3,773,700 shares worth $197M. The largest sale was CR Bard Inc., an estimated $455M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q4 2017 buy was Alphabet (Google) Class C: 3,773,700 shares worth $197M.
- Renaissance Technologies added most to ExxonMobil in Q4 2017, an estimated $521M increase.
- Renaissance Technologies's biggest Q4 2017 reduction was NetEase, cutting an estimated $451M.
- Renaissance Technologies fully exited CR Bard Inc. in Q4 2017, selling an estimated $455M.
- Renaissance Technologies's ten largest holdings make up 8.4% of its $90.7B portfolio in Q4 2017.
- Renaissance Technologies opened 521 new positions and closed 386 in Q4 2017.
- Renaissance Technologies's portfolio value rose 6.7% quarter-over-quarter to $90.7B.
Based on Renaissance Technologies's 13F filing for Q4 2017, filed 13 Feb 2018.